Last Chance to Save!

If you have any questions about registrations for the Fierce JPM Week 2026, please contact us here.

You qualify for a Primary Pass if you work for an organization directly involved in drug, therapy, or medical technology development, or if you are an investor in these sectors. This includes:

Pharma, Biotech & Drug Developers

Companies that:

• Develop or commercialize prescription drugs, biologics, gene or cell therapies

• Maintain an internal R&D pipeline or proprietary therapeutic technology

Medical Device & Diagnostics

Companies that:

• Develop or manufacture medical devices, diagnostics, or clinical technologies

• Conduct clinical or regulatory activities tied to medical innovation

Investors

Firms that:

• Invest in biotech, pharma, medtech, or diagnostics companies

• Include venture capital, private equity, and family offices focused on life sciences

Attendees are welcome to book directly with the Hyatt Regency San Francisco, but there will not be a special attendee rate or room block available.

Please read our cancelation policy and terms & conditions carefully as they contain important information about your event registration.

To apply for a press pass, please contact us today.

At Questex, we take your privacy seriously and we do not sell your personal data to ANY third parties. If you see an email from a company claiming to have an attendees list from our events, please know that they are NOT affiliated with Questex and are FRAUD, do not respond or engage with them.